AEterna Zentaris Inc. (AEZS)

[chmcnfunds]

STICKY FACT CHECK. Sticky has many erroneous statements. A few from the prior sticky have been corrected but these remain. Here are the bolded checks that are the most glaring. If you agree, feel free to re-post this information. Time to have this sticky updated.

Btw final phase 3 results for ZopTec in endometrial cancer wi be released by the end of 2016.

Expected to be completed by the end of 2016. Results likely later sometime in 2017 and AEZS known for being late in announcing results.

AEZS is now officially a US based company with an extra office in Germany

Not officially -- may want to wait until the company announces later this year.


Price estimate on this excellent news:
$.50-$1.23
.50= 300 million dollar market cap based on max diluted shares after warrant conversion and on the Adam Feuerstein biotech oncology rule that biotech firms should be valued at least 300 million dollar before the final FDA approval comes

300 million market cap WRONG. Misunderstanding of the Feuerstein-Reitan Rule. Has nothing to do with determining price estimates. Rather it establishes the minimal market cap for a company to to be successful. So AEZS, with a current market cap of approximately $14M-$16M, based on ihub detailed quote, Finviz and Google Finance, according to this “rule” has little chance for success. More on the F-R Rule:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116949306

1.23=consensus price target of 6 analysts

There are not six analysts who have a consensus target of 1.23. I challenge you to name them and provide a link.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117565259

The company has sufficient cash until February2017

While true they have cash until February, 2017 it is hardly “sufficient”. They will be down to 0 cash which would severely restrict them. Historically AEZS does an offering whenever cash gets down to about $35M.

Finally, left unsaid is the fact they are facing Nasdaq delisting and are expected to respond to this by mid November by doing a reverse split. Expect an offering after that.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117417542

(I have no shares)

AEZS